1,705
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

The in cis compound EGFR mutations in Chinese advanced non-small cell lung cancer patients

ORCID Icon, , , , , , , , , , , , , & show all
Pages 1097-1104 | Received 31 Oct 2018, Accepted 25 Dec 2018, Published online: 16 Apr 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Lvxia Dai, Xiaoping Yu, Sizhou Huang, Yanjuan Peng, Jianmin Liu, Tian Chen, Xin Wang, Qiaofeng Liu, Yanfeng Zhu, Dengbang Chen, Xiaohua Li, Yu Ou, Yi Zou, Qu Pan & Kang Cao. (2021) The therapeutic potential of attenuated diphtheria toxin delivered by an adenovirus vector with survivin promoter on human lung cancer cells. Cancer Biology & Therapy 22:1, pages 79-87.
Read now
Xuhui Zhang, Jiemei Feng, Xiaoxing Su, Yan Lei, Wendy Wu & Xiangyang Cheng. (2020) Next Generation Sequencing Reveals a Synchronous Trilateral Lung Adenocarcinoma Case with Distinct Driver Alterations of EGFR 19 Deletion or EGFR 20 Insertion or EZR-ROS1 Fusion. OncoTargets and Therapy 13, pages 12667-12671.
Read now
Xiang Long, Tian Qin & Junhong Lin. (2020) Great Efficacy of Afatinib in a Patient with Lung Adenocarcinoma Harboring EGFR L833V/H835L Mutations: A Case Report. OncoTargets and Therapy 13, pages 10689-10692.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.